Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Business Wire
Underscores Proven Innovation Model, Robust and Diversified Pipeline with 12 Potential Blockbuster1 Candidates, and Unmatched Scale and CapabilitiesAnimal Health Leader Positioned to Deliver Sustained Revenue Growth, Profitability and Shareholder Value PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, will host an Innovation Webcast today at 8:30 a.m. ET to provide an update on its proven innovation model, robust and diversified R&D pipeline, and upcoming growth catalysts as the company continues pioneering the future of animal health.“The pace of animal health innovation is accelerating alongside a growing appreciation for the essential role animals play in our lives and communities. As the industry leader in innovation, Zoetis is leveraging our unmatched expertise, capabilities and scale to expand into new categories of care, advance next-generation therapies and define the industry’s next decade,” said Kristin Peck, Chief Exec
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]Yahoo! Finance
- Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in CatsBusiness Wire
- Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.MarketBeat
- Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]Seeking Alpha
ZTS
Earnings
- 11/4/25 - Beat
ZTS
Sec Filings
- 12/2/25 - Form 3
- 12/2/25 - Form 4
- 12/2/25 - Form 8-K
- ZTS's page on the SEC website